Cell Line Genetics is the leading provider of stem cell characterization and multispecies quality assurance services and products specifically designed to ensure the genetic integrity and authentication of adult and pluripotent stem cell lines.

As a leader in the Stem Cell and Regenerative Medicine field CLG has the track record and technical expertise to meet the demanding needs of the leading universities and research institutes, as well as biotechnology and pharmaceutical companies worldwide.

Cell Line Genetics is an independent and privately owned company, not affiliated with any academic institutions, research institutes, or government-funded laboratories. Confidentiality is guaranteed.

Latest News:

Agilent Technologies, Cell Line Genetics Collaborate on High-Throughput Cell-Line Characterization Services for Regenerative Medicine, Cancer Researchers
Agilent Technologies Inc. (NYSE: A) today announced a collaboration with Cell Line Genetics, Inc.(CLG), a leading provider of cell-line characterization and quality assurance services. CLG will develop high-throughput, genomic characterization workflows to confirm and monitor the integrity of cell lines for translational and regenerative medicine research. The workflows will be based upon Agilent's custom, targeted CGH+SNP microarrays and SureFISH technology. Learn More
Posted: 02/17/2014

Cell Line Genetics Inc. sponsors and exhibits at the World Stem Cell Summit in San Diego, CA.
The 9th World Stem Cell Summit was held in San Diego, CA on December 4-6, 2013. Cell Line Genetics was proud to serve as a Bronze sponsor and exhibitor. Rob Herrera, President of Cell Line Genetics, spoke in a well received session on Translational Challenges for Regenerative Medicine. Cell Line Genetics commends the Genetics Policy Institute for their leadership and commitment to the field. Learn More
Posted: 12/20/2013

Cell Line Genetics Marks 7,500 Quality Assurance Cases in the Field of Stem Cell Research & Regenerative Medicine
MADISON, Wis. & NEW YORK--(BUSINESS WIRE)--Cell Line Genetics, Inc. (“CLG”), a leader in Stem Cell Quality Assurance (“QA”) services and products, announced today that it has performed QA services on over 7,500 stem cell samples. The company concurrently announced significant additions to both its management and scientific teams: Robert Margolin has been appointed to Director of Marketing, and the company expanded its research and product development team in Madison, Wisconsin. Learn More
Posted: 06/08/2011

Cell Line Genetics Honored as One of the 2011 “Wisconsin Companies to Watch”
MADISON, Wis. & NEW YORK--(BUSINESS WIRE)--Cell Line Genetics, LLC (“CLG”), a leader in Stem Cell Quality Assurance (“QA”) services and products, has been recognized as one of the thirty-three 2011 “Wisconsin Companies to Watch,” an awards program presented by the Wisconsin Entrepreneurs’ Network (WEN) with support from the Wisconsin SBDC Network and the Division of Entrepreneurship and Economic Development (DEED) at the University of Wisconsin-Extension in association with the Edward Lowe Foundation. Learn More
Posted: 05/20/2011